Immatics
IMTX
$10.26
Share price
0.29%
Change (1 day)
48.27%
Change (1 year)
Categories
Revenue for Immatics (IMTX)
Revenue in 2023 (TTM): $58.83 M
According to Immatics's latest financial reports the company's current revenue (TTM) is $58.83 M. In 2022 the company made a revenue of $0.18 B an increase over the years 2021 revenue that were of $40.14 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immatics from 2020 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $58.83 M | -68.7% |
| 2022 | $0.18 B | 368.28% |
| 2021 | $40.14 M | 10.33% |
| 2020 | $36.38 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | $0.14 B | 152.52% | 🇺🇸 USA |